Lung cancer vaccine poised to begin phase IIb/III trials
September 1, 2010Research and Development NSCLC, TG4010, Transgene, cancer vaccine
French biotech firm Transgene has received positive scientific advice from the EMA for late stage trials of its new lung …
Eye treatment could be commercial breakthrough for ThromboGenics
September 1, 2010Research and Development ThromboGenics, eye care, microplasmin
Belgian biopharma company ThromboGenics could have a major product on its hands in the shape of new eye treatment. The …
EMA to assess GSK flu vaccine for narcolepsy link
September 1, 2010Research and Development, Sales and Marketing GlaxoSmithKline, Pandemrix, h1n1
The European Medicines Agency has launched a review of GlaxoSmithKline’s influenza vaccine Pandemrix. The European Commission asked the EMA to …
Pharma and the iPhone: there’s an app for that
September 1, 2010Medical Communications, Research and Development, Sales and Marketing ipad, iphone
The iPhone and its new, larger cousin the iPad, have captured the hearts of many technology lovers, and have ushered …
Kendle appoints Mark Roseman chief marketing officer
September 1, 2010Research and Development Kendle, appointment, research and development
Mark Roseman has joined clinical research organisation Kendle as senior vice president and chief marketing officer. He has more than …
Talking R&D: Strategic vs full service CRO
September 1, 2010Research and Development CRO, Talking Point, Talking R&D
CRF Health’s Greg Jewett and Medpace’s Alita Hassan debate the merits of a strategic or a full service contract research …
Roche coy on job cut reports
September 1, 2010Manufacturing and Production, Research and Development, Sales and Marketing Roche, job cuts
Roche is reportedly set to cut thousands of pharma jobs to reduce costs and boost profitability following a series of …
Paul Phull joins PharmaVentures
August 31, 2010Sales and Marketing PharmaVentures, appointment, sales and marketing
Oxford, UK-based PharmaVentures has appointed Paul Phull as a senior director to its corporate advisory business. He joins the company …
Swiss approval for Novartis’ Tasigna
August 31, 2010Sales and Marketing Novartis, Tasigna, Tekamlo
Novartis’ Tasigna has received its first European approval as a first-line treatment after Swiss authorities green-lighted the blood cancer drug …
Sanofi’s $18.5bn bid for Genzyme rejected
August 31, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis
Sanofi-Aventis has gone public with its $18.5 billion offer for Genzyme after the US biotech’s board unanimously rejected the bid …
Lonza buys Vivante to get bigger in biologics
August 31, 2010Manufacturing and Production Lonza, Vivante
Swiss contract manufacturer and fine chemicals firm Lonza has expanded its biologics production capacity with the purchase of US firm …
Swiss API manufacturer opens high-potency plant
August 31, 2010Manufacturing and Production API, Cerbios-Pharma
Cerbios-Pharma SA of Switzerland has officially opened its new high-potency active pharmaceutical ingredient manufacturing plant in Barbengo, a district in …
Hyaluron pulled up over particle contamination
August 31, 2010Manufacturing and Production Hyaluron, manufacturing compliance
US manufacturer Hyaluron has been sent a warning letter by the FDA after a routine inspection uncovered concerns with aseptic …
SOCMA welcomes US law easing raw material imports
August 27, 2010Manufacturing and Production Obama, SOCMA
US President Barack Obama has signed into law the Manufacturing Enhancement Act of 2010, designed to do away with import …
Chandler Chicco expands European services with Wright appointment
August 27, 2010Medical Communications Chandler Chicco, Cohn & Wolfe, Europe
Chandler Chicco has appointed Alison Wright to a newly created post to help increase the agency’s European and global services …
US prescription drug prices rise above inflation
August 27, 2010Sales and Marketing US, prices
A new study of US medicines has found that prices rose 8.3% on average in 2009, well above inflation and …
US court bars stem cell funding
August 26, 2010Sales and Marketing Obama, Stem cells, US
A US district court has temporarily blocked plans to increase government funding of stem cell research in the country. The ruling …
CMC Bio unveils disposable biomanufacturing facility
August 26, 2010Manufacturing and Production CMC Biologics, disposables
Contract manufacturer CMC Biologics has completed the construction of a new manufacturing facility at its site in Bothell near Seattle …
J&J chalks up ninth product recall in 2010
August 26, 2010Manufacturing and Production J&J, JJ
Johnson & Johnson has recalled around 100,000 boxes of its disposable contact lens because of a manufacturing defect, bringing the …
Alcon acquisition makes Novartis eyecare leader
August 26, 2010Sales and Marketing Novartis, ophthalmology
Novartis has finalised its takeover of Alcon that will make it the world’s number one company in ophthalmology. Alcon is …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
